🇺🇸 FDA
Patent

US 8551997

Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use

granted A61KA61K31/7088A61P

Quick answer

US patent 8551997 (Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use) held by The Board of Regents of the University of Texas System expires Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K31/7088, A61P, A61P35/00